Medical devices, healthcare technology and the business of care
510(k) clearance · K260251

BreathCare PAP III (YH-390N)

Suzhou Yuyue Medical Technology Co., Ltd. · Decision date Oct 23, 2026

MEDTECHLEDGER EXPLANATIONK260251

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision on 2026-10-23 for K260251, a traditional 510(k) submitted 01/27/2026 by Suzhou Yuyue Medical Technology Co., Ltd. of Suzhou, CN. The device is BreathCare PAP III (YH-390N), listed under classification name Ventilator, Non-Continuous (Respirator), regulation 868.5905, product code BZD, with anesthesiology as the regulation medical specialty and review panel. SESE indicates clearance to market, not PMA approval.

The record shows no third-party review, no combination product designation, and no authorized predetermined change control plan. The listed correspondent is the same firm, with Fang Zhang as contact for both applicant and correspondent. The source does not describe device components, the technological characteristics compared with a predicate, or the basis for the equivalence finding; those details would sit in the underlying 510(k) review documents, which are not included here. No clinical or performance conclusions are drawn.

The public page was last updated 11/02/2026. Whether the device is currently marketed, and any labeling or indication specifics, remain unknown from this record.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Anesthesiology
Decision date
Oct 23, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K260251
Regulatory pathway
510(k) premarket notification
Product code
BZD
Decision code
SESE
Decision date
Oct 23, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Ventilator, Non-Continuous (Respirator).

Product code
BZD
FDA device class
2

FDA decision timeline

  1. K260251 received

    Application receipt date recorded by FDA.

  2. K260251 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code BZD

Product / regulatory recordCompanyPathwayDecision dateSource
Respironics, Inc.510(k) clearanceSep 25, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Suzhou Yuyue Medical Technology Co., Ltd.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Suzhou

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records